With advanced technology, production equipment, and complete supporting production lines, we have become a bright pearl in the industry of CAS:198470-85-8, CAS:21535-47-7, CAS: 188416-20-8 and have won the trust and praise of new and old customers. Along the road of science and humanization, our corporate culture construction has achieved a lot, but it still has a long way to go. We will use high quality products, preferential prices and sincere service to win the trust of our customers. We use strict quality management and control system as a guarantee, adopt advanced production equipment and technology, absorb and cultivate a large number of outstanding technical personnel and sales personnel, thus our product quality has always been in the leading position in the industry.
This Anagliptin API CAS:739366-20-2 is a pharmaceuticadrus for the treatment of type 2 diabetes mellitus. It is approved for use in Japan. The product belongs to the class of anti-diabetic drues known as dipeptidyl peptidase-4 inhibitors. It is a white to yellow crystalline powder. The product' s purity is high, and its stability is good. Anagliptin has a positive effect on low density lipoprotein levels and is effective in assisting the treatment of type 2 diabetes
This Anagliptin API CAS:739366-20-2 has a broad medical market value. Since we have perfect production quality system, advanced equipment and rigorous scientific research attitude. The quality of the products is excellent and our company can offer long-term supply to you. If you are interested, please feel free to contact us and we will offer you the best service.
Our company continues to build a strong brand in the EDTA Acid with Good Price field with excellent product quality, honest business philosophy and perfect after-sales service. We have confidence to locate our company to a pioneer management standard, more competitive and achieve a first-class grading. To achieve mutual success, we will make our best efforts to build a solid co-operation and transparent communication work with our companions.